Swift, Robert M.

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial

Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 1,930

An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence: Results From the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study

Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 451

Trial of prazosin for post-traumatic stress disorder in military veterans

Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., et al. (2018) · New England Journal of Medicine

Posttraumatic Stress Disorder ResearchSleep and related disorders

Cited by 342

Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders.

MacKillop, J., Miranda, R., Monti, P. M., Ray, L. A., Murphy, J. G., Rohsenow, D. J., McGeary, J. E., Swift, R. M., Tidey, J. W., & Gwaltney, C. J. (2010) · Journal of Abnormal Psychology

Substance Abuse Treatment and OutcomesGambling Behavior and Treatments

Cited by 278

Drug therapy for alcohol dependence

Swift, R. M. (1999) · New England Journal of Medicine

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 255

Naltrexone-induced alterations in human ethanol intoxication

Swift, R. M., Whelihan, W. M., Kuznetsov, O., Buongiorno, G., & Hsuing, H. (1994) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 254

Noradrenergic targets for the treatment of alcohol use disorder

Haass-Koffler, C. L., Swift, R. M., & Leggio, L. (2018) · Psychopharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 117

Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial

Friedmann, P. D., Rose, J. S., Swift, R., Stout, R. L., Millman, R. P., & Stein, M. D. (2008) · Alcoholism Clinical and Experimental Research

Sleep and related disordersSubstance Abuse Treatment and Outcomes

Cited by 116

Studies on a Wearable, Electronic, Transdermal Alcohol Sensor

Swift, R. M., Martin, C. S., Swette, L., LaConti, A., & Kackley, N. (1992) · Alcoholism: Clinical and Experimental Research

Electrochemical sensors and biosensorsAnalytical Chemistry and Sensors

Cited by 114

A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor

Barnett, N. P., Celio, M. A., Tidey, J. W., Murphy, J. G., Colby, S. M., & Swift, R. M. (2017) · Addiction

Substance Abuse Treatment and OutcomesBehavioral and Psychological Studies

Cited by 111

Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans.

Hutchison, K. E., Wood, M. D., & Swift, R. (1999) · Experimental and Clinical Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 108

Transdermal Alcohol Measurement for Estimation of Blood Alcohol Concentration

Swift, R. (2000) · Alcoholism: Clinical and Experimental Research

Forensic Toxicology and Drug AnalysisAdvanced Chemical Sensor Technologies

Cited by 101

Deconvolving an estimate of breath measured blood alcohol concentration from biosensor collected transdermal ethanol data

Dumett, M. A., Rosen, I. G., Sabat, J., Shaman, A., Tempelman, L., Wang, C., & Swift, R. M. (2008) · Applied Mathematics and Computation

Numerical methods in inverse problemsControl Systems and Identification

Cited by 53

Pharmacotherapy for alcoholic patients with alcoholic liver disease

Vuittonet, C. L., Halse, M., Leggio, L., Fricchione, S. B., Brickley, M., Haass-Koffler, C. L., Tavares, T., Swift, R. M., & Kenna, G. A. (2014) · American Journal of Health-System Pharmacy

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 51

The relationship between craving, anxiety, and other symptoms in opioid withdrawal

Swift, R. M., & Stout, R. L. (1992) · Journal of Substance Abuse

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 35

Defining the role of corticotropin releasing factor binding protein in alcohol consumption

Haass-Koffler, C. L., Henry, A. T., Melkus, G., Simms, J. A., Naemmuddin, M., Nielsen, C. K., Lasek, A. W., Magill, M., Schwandt, M. L., Momenan, R., et al. (2016) · Translational Psychiatry

Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology

Cited by 33

Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings

Kenna, G. A., Zywiak, W. H., Swift, R. M., McGeary, J. E., Clifford, J. S., Shoaff, J. R., Fricchione, S., Brickley, M., Beaucage, K., Haass-Koffler, C. L., et al. (2014) · Alcohol

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 20